Key result
Atorvastatin use in patients with Von Willebrand disease and angiodysplasia was discussed, although specific clinical outcomes were not detailed in the abstract.
Authors
Loading...
Atorvastatin lacks outcome data in VWD with angiodysplasia; leaves open any role in angiodysplasia-related bleeding.
Key points are not available for this paper at this time.
Alikhan et al. (2009) studied this question. Atorvastatin use in patients with Von Willebrand disease and angiodysplasia was discussed, although specific clinical outcomes were not detailed in the abstract.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: